Literature DB >> 1929278

Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus.

R J Davidson1, G G Zhanel, R Phillips, D J Hoban.   

Abstract

The postantibiotic effect (PAE) of fluoroquinolones against Staphylococcus aureus was determined in Mueller-Hinton broth and normal human serum. At both 4X and 10X the MIC, serum significantly increased the duration of the PAE in all strains tested (P less than 0.05). Reducing the pH of the serum from 7.9 to 7.2 had no effect on the PAE. Heat treating the serum (56 degrees C, 30 min) reduced the PAE of ciprofloxacin at 10X the MIC approximately 25% (P less than 0.05). The PAE of cloxacillin was reduced approximately 80% in serum, and PAE experiments with gentamicin and cephalexin produced findings similar to those obtained with the fluoroquinolones. Serum increased the MICs of ciprofloxacin and norfloxacin less than twofold and increased the MIC of pefloxacin approximately fourfold. We conclude that normal human serum considerably increases the PAE of fluoroquinolones against S. aureus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929278      PMCID: PMC284328          DOI: 10.1128/AAC.35.6.1261

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

Review 1.  The postantibiotic effect: a review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  DICP       Date:  1991-02

2.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

3.  Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Potentiation of antibiotic bactericidal activity by normal human serum.

Authors:  B S Dutcher; A M Reynard; M E Beck; R K Cunningham
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

6.  In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.

Authors:  R Wise; J M Andrews; J P Ashby; R S Matthews
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

7.  Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.

Authors:  J E Leggett; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

8.  The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.

Authors:  D S Reeves; M J Bywater; H A Holt
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

9.  Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

Authors:  N X Chin; H C Neu
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

  9 in total
  8 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

2.  Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.

Authors:  K Fuursted
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus.

Authors:  G G Zhanel; I D Kirkpatrick; D J Hoban; A M Kabani; J A Karlowsky
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.

Authors:  J A Karlowsky; G G Zhanel; R J Davidson; S R Zieroth; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

5.  In vitro activities and postantifungal effects of the potent dolastatin 10 derivative auristatin PHE.

Authors:  T Woyke; G R Pettit; G Winkelmann; R K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 6.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

7.  Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.

Authors:  G G Zhanel; J A Karlowsky; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

8.  Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus.

Authors:  M R Yeaman; D C Norman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.